title: Response to nimotuzumab in a child with a progressive diffuse intrinsic pontine glioma.
authors.affiliation: Pediatric Oncology Unit, Department of Pediatrics, Departments of Radiology Radiotherapy Pharmacy and Pharmacology, University Hospital Reina Sofía, Córdoba, Spain.
authors.forename: María Elena
authors.initials: ME
authors.lastname: Mateos
authors.forename: Eduardo
authors.initials: E
authors.lastname: López-Laso
authors.forename: Lucía
authors.initials: L
authors.lastname: Izquierdo
authors.forename: Juan Luis
authors.initials: JL
authors.lastname: Pérez-Navero
authors.forename: Sonia
authors.initials: S
authors.lastname: García
authors.forename: Cruces
authors.initials: C
authors.lastname: Garzás
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D020295:Brain Stem Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000532:radiotherapy; D002648:Child; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018450:Disease Progression; D066246:ErbB Receptors / Q000378:metabolism; D006801:Humans; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D011149:Pons; D000077204:Temozolomide
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018906:Antineoplastic Agents, Alkylating; C501466:nimotuzumab; D003606:Dacarbazine; D066246:ErbB Receptors; D000077204:Temozolomide